Kazia Therapeutics Limited (NASDAQ: KZIA) shares are trending on Wednesday. Check out the current price of KZIA stock here. KZIA surged 51.74% in after-hours trading to $8.74 on Tuesday following the ...
Shares of Kazia Therapeutics Ltd (NASDAQ:KZIA) are surging Wednesday following the announcement of preclinical research findings for its lead drug candidate, paxalisib. The research, conducted at the ...
SYDNEY, Nov. 10, 2023 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the publication in Molecular Cancer ...
SYDNEY, June 27, 2024 /PRNewswire/ -- Kazia Therapeutics Limited (KZIA), a biotechnology company specialising in oncology, is pleased to announce the presentation of new data from its lead program, ...
SYDNEY, Nov. 1, 2023 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to provide a preliminary update from the ongoing ...
SYDNEY, Nov. 18, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (Nasdaq: KZIA), an oncology-focused drug development company, today announced that a patient with stage IV triple-negative breast ...
SYDNEY, Oct. 7, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced an exclusive collaboration and in-licensing agreement (the ...
Hosted on MSN
Kazia Therapeutics secures $46.5 million through private placement to address Nasdaq compliance
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results